JUPITER NEUROSCIENCES INC JUNS
$0.22
+3.7% 52w: $0.20 – $2.97
Latest 13F among current holders filed 1 month ago (May 21, 2026)
Price — last 12 months
research preview data0.201.592.97
Jun 20, 2025 Jul 2, 2026
Institutional holders
10
-2 QoQ
13F value
$716K
+9.8% QoQ
Smart-money holders
1
signal tier ≥ 2
New smart buyers
0
Q1 2026
Institutional value by quarter
Number of holders
Who owns JUNS?
Q1 2026 filings| Fund | Type | Shares | Value | % of fund | Change |
|---|---|---|---|---|---|
| VESTOR CAPITAL, LLC | Other | 971.0K | $365K | 0.0% | +144607.2% |
| VANGUARD CAPITAL MANAGEMENT LLC | Diversified mechanical | 359.9K | $135K | 0.0% | — |
| GEODE CAPITAL MANAGEMENT, LLC | Index provider | 211.7K | $80K | 0.0% | +59.6% |
| Yorkville Advisors Global, LP ★2 | Fundamental concentrated | 129.0K | $49K | 0.0% | -2.2% |
| CITADEL ADVISORS LLC | Multistrat pod | 101.7K | $38K | 0.0% | New |
| VANGUARD FIDUCIARY TRUST CO | Diversified mechanical | 87.8K | $33K | 0.0% | — |
| NORTHERN TRUST CORP | Index provider | 25.3K | $10K | 0.0% | Held |
| Virtu Financial LLC | Market maker | 13.6K | $5K | 0.0% | New |
| UBS Group AG | Bank broker | 3.9K | $1K | 0.0% | New |
| MidFirst Bank | Other | 1.0K | $376 | 0.0% | Held |
Exits are not a bearish signal: our backtest shows stocks specialists exit keep outperforming for 3+ quarters — selling usually means profit-taking, not a forecast.
Explore related
Top funds holding JUNS
More healthcare stocks held by institutions